Resource directory · Weight-loss medication
Wegovy, Zepbound, Ozempic and compounded copies get talked about as if they were the same thing. They aren't, and the coverage rules differ again. We built WeightLoss.help to explain the medicines from their FDA prescribing information, the cost from the manufacturers' own price pages, and the coverage from CMS and each state's Medicaid documents, then pair it with a finder for doctors who treat obesity. The site is not a clinic or pharmacy and gives no medical advice.
The Problem
A reader asking about a GLP-1 is usually sorting out three things at once: which drugs are approved for weight loss, what they cost without insurance, and whether Medicare or Medicaid will pay. The site separates them. Ozempic and Mounjaro pages say at the top that they are approved for type 2 diabetes, not weight loss. Compounded semaglutide and tirzepatide get FDA's position only, and no compounding pharmacy is named or linked.
Doses appear only as the label states them, and the site never suggests one of its own. A weight-loss figure appears only as printed in the label's trial results, with the trial named. There are no testimonials or before-and-after photos. Each drug and each state has one research record with the value, source, link and checked date, so a price or coverage rule reads the same on every page that uses it.
The Research Tools
Two pages carry most of the comparison: one lines up the medicines, the other answers whether a state's Medicaid program pays for them.
Medications
The medications hub lists the nine drugs FDA has approved for chronic weight management, from Wegovy and Zepbound to Contrave, Qsymia, phentermine and orlistat. The table shows each ingredient, how it is taken according to the label, and the manufacturer's list price where one is published. Ozempic and Mounjaro sit in a separate group marked as diabetes medicines.
Compare the weight-loss medicationsMedicaid Coverage
Of the 51 Medicaid programs checked, 10 cover GLP-1s such as Wegovy or Zepbound for weight loss, always with prior authorization. The page explains how those states decide who qualifies, what many of the others still cover for heart risk, MASH or sleep apnea, which states changed their rules in 2025 and 2026, and where bariatric surgery fits.
Check Medicaid coverage by stateWho Uses the Research
Link earning starts with the person who would need the resource. The architecture makes that path explicit instead of publishing content first and hunting for a reason to promote it later.
| Primary Evidence | Published Resource | Who Uses It |
|---|---|---|
| FDA prescribing information on DailyMed, and FDA statements | Medication pages, dose schedules and the compounded GLP-1 guide | Readers comparing medicines before talking to a clinician |
| CMS, Medicare.gov and state Medicaid program documents | Medicare, Medicare GLP-1 Bridge and state-by-state Medicaid pages | Medicare and Medicaid enrollees checking coverage |
| CMS NPPES NPI Registry and Medicare Part D Prescribers, 2024 | The doctor finder and practice lists on state and city pages | People looking for a clinician who treats obesity |
Explore the Site
Open the live doctor finder and the most-read cost and coverage guides.
Build
Project Scope
Related Work
An education resource comparing online nutrition degree programs.
A directory of 12,467 SAMHSA-listed mental health facilities, filterable by cost, Medicaid and telehealth.
A finder for SAMHSA-listed addiction treatment facilities with payment filters and no paid listings.
We tie every figure to the official source, mark what the source doesn't say, and keep the pages consistent as the facts change.
Start Your Project